|
|
|
40
|
0013AZ
|
LEVOCETIRIZINE 2.5MG/ML SYR (CIR/AHI)
|
LEVOCETIRIZINE
|
LEVOCETIRIZINE
|
60ML
|
C
|
5.71
|
0.10
|
SYRUP
|
0
|
ML
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTIHISTAMINICS
|
|
|
|
|
40
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR/AHI)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
1.90
|
1.90
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
2.07
|
2.0659
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
0452AT
|
CO-TRIMOXAZOLE 40MG/ML|8MG/ML SUSP (CIR) SULFAMETHOXAZOLE|TR
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
100ML
|
A
|
4.89
|
0.05
|
ML
|
200
|
BOTT
|
CIR
|
CIRON PHARMA
|
CWS
|
CAPSULE WHOLESALE
|
|
081220
|
SULPHONAMIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
SULPHONAMIDES
|
|
|
|
|
40
|
0742X
|
BENZTROPINE 1MG/ML INJ (CIR/AHI)
|
BENZTROPINE
|
BENZTROPINE
|
2ML
|
B
|
5.11
|
5.11
|
INJECTION
|
0
|
AMP
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283608
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
09415
|
PANCURONIUM BROMIDE 2MG/ML INJ (CIR (B)
|
PANCURONIUM BROMIDE
|
PANCURONIUM BROMIDE
|
10X2ML
|
B
|
52.3
|
5.2301
|
AMP
|
0
|
BOX
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
41
|
1133FS
|
ATORVASTATIN 40MG TAB (CIR)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
2.01
|
0.0671
|
TAB
|
60
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1181EV
|
CILENOL 2.5MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
30'S
|
A
|
2.75
|
0.09
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
40
|
1182EQ
|
CILENOL 5MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
30'S
|
A
|
4.24
|
0.14
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1184M
|
CILENOL 10MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
3X10
|
A
|
5.06
|
0.17
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1201Q
|
DORZOL-T 2% | 0.5% EYE DR (CIR/AHI) DORZOLAMIDE
|
DORZOLAMIDE|TIMOLOL
|
DORZOL-T
|
10ML
|
A
|
21.61
|
21.61
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Ophthalmic
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
12116
|
ANGIRON 0.5MG SL TAB (CIR/AHI) GLYCERYL TRINI
|
GLYCERYL TRINITRATE
|
ANGIRON
|
30'S
|
A
|
11.53
|
11.53
|
TABLET
|
30
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
241208
|
NITRATES AND NITRITES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
23717
|
XYLOMETAZOLINE 0.1% NASAL DR (CIR/AHI)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.66
|
2.66
|
NASAL DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
2373S
|
XYLOMETAZOLINE 0.05% NASAL DR (CIR/AHI)
|
XYLOMETAZOLINE
|
XYLOMETAZOLINE
|
10ML
|
A
|
2.31
|
2.31
|
NASAL DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5232
|
EENT VASOCONSTRICTORS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
2562C
|
DIMENHYDRINATE 3MG/ML SYR (CIR/AHI)
|
DIMENHYDRINATE
|
DIMENHYDRINATE
|
150ML
|
A
|
4.54
|
0.03
|
SYRUP
|
125
|
ML
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5622
|
ANTIEMETICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
2691AA
|
HYDROCORTISONE SOD SUCC 100MG INJ (CIR/AHI)
|
HYDROCORTISONE SODIUM SUCCINATE
|
HYDROCORTISONE SOD SUCC
|
100MG VIAL
|
B
|
1.98
|
1.98
|
INJECTION
|
0
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2691AA
|
HYDROCORTISONE SOD SUCC 100MG INJ (CIR) (B)
|
HYDROCORTISONE SODIUM SUCCINATE
|
HYDROCORTISONE SOD SUCC
|
100MG VIAL
|
B
|
2.31
|
2.3106
|
VIAL
|
0
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
40
|
26935
|
HYDROCORTISONE SOD SUCC 500MG INJ (CIR/AHI)
|
HYDROCORTISONE SODIUM SUCCINATE
|
HYDROCORTISONE SOD SUCC
|
50X500MG
|
B
|
268.95
|
5.38
|
INJECTION
|
0
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
2721N
|
TRIAMCINOLONE 40MG/ML INJ (CIR/AHI)
|
TRIAMCINOLONE
|
TRIAMCINOLONE
|
1ML VIAL
|
B
|
2.99
|
2.99
|
INJECTION
|
0
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2721N
|
TRIAMCINOLONE 40MG/ML INJ (CIR) (B)
|
TRIAMCINOLONE
|
TRIAMCINOLONE
|
1ML VIAL
|
B
|
3.29
|
3.2892
|
VIAL
|
4
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ADRENALS
|
|